MHRA-100273-PIP03-24

Key Facts

Active Substance
Active Substance:
  • Derivative of 6-[2-(pyridin-2- yl)phenoxy]methyl}- 1,2,3,4-tetrahydroisoquinoline
Invented Name
Not available at present
PIP Number MHRA-100273-PIP03-24
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral formulation
Therapeutic area
Therapeutic area:
  • Gastroenterology-Hepatology
Conditions / Indications
Conditions / Indications:
  • Treatment of portal hypertension
Route(s) of administration
Route(s) of administration:
  • Oral use
PIP applicant
Decision Type
Decision Type
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Derivative of 6-[2-(pyridin-2-yl)phenoxy]methyl}- 1,2,3,4-tetrahydroisoquinoline.pdf
Published Date 15/08/2024